Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro Musi

Showing results (81-90 of 265) with videos related to

Pageof 27
Sort By:
BJU International|October 4, 2016
Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomesMatteo Ferro, Danilo Bottero, Carolina D'Elia, et al.
American Journal of Clinical Oncology|February 22, 2020
Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer CenterGaetano Aurilio, Elena Verri, Samuele Frassoni, et al.
Clinical Genitourinary Cancer|June 12, 2019
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After OrchiectomyFrancesco A Mistretta, Elio Mazzone, Carlotta Palumbo, et al.
International Journal of Molecular Sciences|March 11, 2023
Radiogenomics in Renal Cancer Management-Current Evidence and Future ProspectsMatteo Ferro, Gennaro Musi, Michele Marchioni, et al.
Urologic Oncology|December 17, 2009
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2008
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patientsBarbara A Jereczek-Fossa, Andrea Vavassori, Cristiana Fodor, et al.
BJU International|April 10, 2014
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapyBarbara A Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score AnalysisGiulia Marvaso, Delia Ciardo, Sara Gandini, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Molecular Imaging Diagnosis of Renal Cancer Using <sup>99m</sup>Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel TechniquesOctavian Sabin Tataru, Michele Marchioni, Felice Crocetto, et al.
Urologic Oncology|July 1, 2020
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic samplingStefano Luzzago, Giuseppe Petralia, Duilia Maresca, et al.
Pageof 27

Showing results (81-90 of 265) with videos related to

Sort By:
Pageof 27
BJU International|October 4, 2016
Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomesMatteo Ferro, Danilo Bottero, Carolina D'Elia, et al.
American Journal of Clinical Oncology|February 22, 2020
Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer CenterGaetano Aurilio, Elena Verri, Samuele Frassoni, et al.
Clinical Genitourinary Cancer|June 12, 2019
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After OrchiectomyFrancesco A Mistretta, Elio Mazzone, Carlotta Palumbo, et al.
International Journal of Molecular Sciences|March 11, 2023
Radiogenomics in Renal Cancer Management-Current Evidence and Future ProspectsMatteo Ferro, Gennaro Musi, Michele Marchioni, et al.
Urologic Oncology|December 17, 2009
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2008
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patientsBarbara A Jereczek-Fossa, Andrea Vavassori, Cristiana Fodor, et al.
BJU International|April 10, 2014
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapyBarbara A Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score AnalysisGiulia Marvaso, Delia Ciardo, Sara Gandini, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Molecular Imaging Diagnosis of Renal Cancer Using <sup>99m</sup>Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel TechniquesOctavian Sabin Tataru, Michele Marchioni, Felice Crocetto, et al.
Urologic Oncology|July 1, 2020
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic samplingStefano Luzzago, Giuseppe Petralia, Duilia Maresca, et al.
Pageof 27